IRIS
ANGELICO, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 87.153
EU - Europa 5.356
AS - Asia 2.920
SA - Sud America 37
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 13
OC - Oceania 13
Totale 95.508
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 87.125
SG - Singapore 1.333
UA - Ucraina 1.210
CN - Cina 1.086
DE - Germania 981
IE - Irlanda 764
IT - Italia 518
SE - Svezia 455
RU - Federazione Russa 396
KR - Corea 334
FI - Finlandia 258
FR - Francia 245
GB - Regno Unito 228
PL - Polonia 177
BE - Belgio 39
JP - Giappone 38
VN - Vietnam 31
CZ - Repubblica Ceca 24
IN - India 24
CA - Canada 23
BR - Brasile 22
NL - Olanda 15
RO - Romania 14
HK - Hong Kong 13
AU - Australia 12
CL - Cile 10
EU - Europa 10
PK - Pakistan 10
CH - Svizzera 8
IL - Israele 7
A2 - ???statistics.table.value.countryCode.A2??? 6
EG - Egitto 6
IR - Iran 6
KG - Kirghizistan 6
TR - Turchia 6
ET - Etiopia 5
ES - Italia 4
TM - Turkmenistan 4
TW - Taiwan 4
DM - Dominica 3
GR - Grecia 3
KZ - Kazakistan 3
LK - Sri Lanka 3
EC - Ecuador 2
HU - Ungheria 2
IQ - Iraq 2
LU - Lussemburgo 2
MN - Mongolia 2
NO - Norvegia 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
BG - Bulgaria 1
DK - Danimarca 1
EE - Estonia 1
ID - Indonesia 1
LT - Lituania 1
MD - Moldavia 1
MX - Messico 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
SI - Slovenia 1
SV - El Salvador 1
TH - Thailandia 1
VA - Santa Sede (Città del Vaticano) 1
Totale 95.508
Salva come PNG Salva come JPEG
Città #
Woodbridge 27.064
Wilmington 23.543
Houston 21.597
Fairfield 2.718
Ann Arbor 1.968
Singapore 1.136
Jacksonville 1.127
Ashburn 1.123
Seattle 1.104
Chandler 1.082
Cambridge 912
Dublin 745
Medford 575
Dearborn 515
Beijing 414
Santa Clara 289
Lawrence 267
Rome 221
New York 203
Zhengzhou 202
Mülheim 190
Kraków 174
Hangzhou 136
San Diego 135
Menlo Park 121
Milan 77
Moscow 77
Palo Alto 54
Shanghai 52
University Park 52
Mountain View 46
Hefei 42
Falls Church 40
Norwalk 40
Redwood City 38
Boardman 36
San Mateo 36
Brussels 34
Nanjing 32
Verona 32
Detroit 30
San Francisco 28
London 27
Guangzhou 25
Kunming 23
Indiana 20
Seoul 20
Hanoi 18
Helsinki 18
Jinan 16
Los Angeles 16
Munich 15
Nanchang 15
Saint Petersburg 15
Phoenix 14
São Paulo 14
Olomouc 13
Creede 12
Iasi 11
Toronto 11
Auburn Hills 9
Colorado Springs 9
Dong Ket 9
Seongnam 9
Brno 8
Chengdu 8
Frankfurt am Main 8
Fuzhou 8
Hebei 8
Hong Kong 8
Nuremberg 8
Redmond 8
Shenyang 7
Changsha 6
Groningen 6
Wuhan 6
Ypsilanti 6
Chiswick 5
Hounslow 5
Lahore 5
Mcallen 5
New Bedfont 5
The Dalles 5
Yellow Springs 5
Antwerp 4
Bologna 4
Canberra 4
Engelhard 4
Florence 4
Fremont 4
Irvine 4
Kilburn 4
La Veta 4
San Jose 4
Shaoxing 4
Simi Valley 4
Storm Lake 4
Taipei 4
Washington 4
Almaty 3
Totale 88.839
Salva come PNG Salva come JPEG
Nome #
Crusted scabies in a liver transplant patient mimicking rupioid psoriasis 1.355
Boceprevir for untreated chronic HCV genotype 1 infection. 545
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 512
Transport, utilization and biliary secretion of lysophosphatidylcholine in the rat liver 478
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice 455
Unfavourable effects of colchicine in combination with interferon-alpha in the treatment of chronic hepatitis C 451
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 446
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 446
Operational tolerance in clinical liver transplantation: emerging developments. 445
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 444
Recurrence of insulin resistant metabolic syndrome following liver transplantation 442
Correlation between liver fibrosis and inflammation in patients transplanted for HCV liver disease 441
Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans 440
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 439
Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization 439
Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia 436
Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports 436
Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection 434
Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers 432
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 429
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C. 427
Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats 425
Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. 424
In vivo, high field, 3-Tesla H MR spectroscopic asessment of liver in fibrosis in HCV-correlated chronic liver disease Valutazione in vivo della fibrosi epatica in corso di epatopatia cronica HCV con spettroscopia H-RM 3T 423
Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs. 423
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 423
Ribavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivo. 422
Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders 421
A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: The TT4 randomized trial 421
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 420
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study 420
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice 420
Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late 420
Liver elasticity in NASH patients evaluated with real-time elastography (RTE). 418
Interposition of the right colic angle between the liver and thoracic wall: an unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient. 415
Leptin attenuates ischemia-reperfusion injury in the rat liver. 415
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 414
Quasielastic light scattering evidence for vesicular secretion of biliary lipids 413
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. 412
N-ethyl-tauroursodeoxycholic acid, a novel deconjugation-resistant bile salt analogue: effects of acute feeding in the rat 411
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 411
A randomized controlled trial of amantadine plus interferon-alpha 2a vs. interferon-alpha 2a alone in naive patients with chronic hepatitis C randomized according to the early virological response to interferon-alpha 2a monotherapy 410
High performance liquid chromatographic analysis of molecular species of phosphatidylcholine--development of quantitative assay and its application to human bile 410
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. 409
Comment on the PROVE1 and PROVE2 clinical trials: "I was taking a picture of Rapid Virological Response with telaprevir, but the background is unfocused!". 409
Effect of glucose and/or branched chain amino acid infusion on plasma amino acid imbalance in chronic liver failure 409
Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study 409
Hepatitis C reinfection after liver transplantation in relation to virus genotype 408
Portal vein thrombosis after radiofrequency ablation of HCC 408
Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection 408
Interposition of the right colic angle between the liver and thoracic wall: An unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient 407
Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension 406
Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha 404
596 403
Lamellar bodies coexist with vesicles and micelles in human gallbladder bile. Ursodeoxycholic acid prevents cholesterol crystal nucleation by increasing biliary lamellae 403
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors 403
Clinical trial: low plasma cholesterol and oxidative stress predict rapid virological response to standard therapy with peginterferon and ribavirin in HCV patients 403
Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation. 402
Liver contrast enhanced ultrasound perfusion imaging in the evaluation of chronic hepatitis C fibrosis: preliminary results 402
Assembly of biliary lipids in native hepatic bile after orthotopic liver transplantation: a biochemical and ultra-structural study in humans 401
Metabolic findings after liver transplantation within a randomised trial with or without steroids 401
Spontaneous resolution of severe acute rejection in liver transplantation. 400
Specific HBSAG Genetic- Determinants are associated with occult HBV-infection in vivo and HBSAG detection 400
Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis 399
Extended double-dosage HBV vaccination after liver transplantation is ineffective, in the absence of lamivudine and prior wash-out of human Hepatitis B immunoglobulins 399
Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development 398
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 398
Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: report of two successful cases. 397
Skills and requirements of a transplant hepatologist: board certification of the Italian Association for the Study of the Liver (AISF) 397
Retrospective analysis of 30 patients who underwent liver transplantation without use of steroids 396
Dissolution of human cholesterol gallstones in bile salt/lecithin mixtures: effect of bile salt hydrophobicity and various pHs 396
The meaning of serum bile acid patterns 395
Sulfated bile acids in serum, bile, and urine of cirrhotic patients before and after portacaval anastomosis 395
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 395
Qualitative patterns of biliary bile acids affect cyclosporine intestinal absorption in liver transplant recipients 394
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. 394
Familial factors determine the development of diabetic nephropathy in patients with IDDM 394
HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome 394
International comparison of liver transplant programmes: differences in indications, donor and recipient selection and outcome between Italy and UK 394
Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease 393
Spontaneous resolution of severe acute rejection in liver transplantation 393
Liver transplantation in the presence of portal vein thrombosis: report from a single center. 392
Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence 392
Influence of portacaval anastomosis on serum and biliary unsulfated bile acid composition in patients with liver cirrhosis 391
Optimal efficacy of interferon-free HCV retreatment after protease inhibitors failure in real life. 391
Is donor age a risk factor for poor graft function after orthotopic liver transplantation? 390
The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation 390
Erythrocyte fatty acid composition and gallstone disease: results of an epidemiological survey 390
Recipient female gender is a risk factor for graft loss after liver transplantation for chronic hepatitis C: Evidence from the prospective Liver Match cohort 390
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 390
Evaluation of B-cell secretion and peripheral insulin resistance during pregnancy and after delivery in gestational diabetes mellitus with obesity 389
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C 388
Long-acting nitrates in portal hypertension: to be or not to be? 388
Epidemiology and outcome of hepatitis C relapse in transplant recipients 387
Liver transplantation for end-stage liver disease related to viral hepatitis 386
Human islet allografts in patients with type 2 diabetes undergoing liver transplantation 386
Gallstones in cystic fibrosis: a critical reappraisal 386
Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis 385
Plasma/erythrocyte ribavirin x100 ratio as an indicator of sustained virological response in HCV genotype 1 patients with early virological response 385
Impaired hepatic handling and processing of lysophosphatidylcholine in rats with liver cirrhosis 384
Totale 42.159
Salva come PNG Salva come JPEG
Categoria #
all - tutte 172.015
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 172.015
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202016.931 0 0 0 0 2.222 2.631 2.180 2.207 2.258 2.093 1.570 1.770
2020/202114.570 1.702 1.781 1.619 1.884 1.487 1.499 1.846 1.386 316 313 576 161
2021/20222.782 122 280 162 157 65 361 121 113 269 248 109 775
2022/20233.217 377 235 125 347 254 745 273 185 300 28 286 62
2023/2024870 134 21 87 20 92 217 15 22 11 23 7 221
2024/20252.531 187 1.299 623 336 86 0 0 0 0 0 0 0
Totale 96.003